Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-27T02:26:23.640Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of microRNAs in immunity and organ transplantation

Published online by Cambridge University Press:  08 December 2011

Janine C. Spiegel ,
Johan M. Lorenzen  and
Thomas Thum
Janine C. Spiegel
Affiliation:
Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
Johan M. Lorenzen
Affiliation:
Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
Thomas Thum*
Affiliation:
Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
*
*Corresponding author: Thomas Thum, Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. E-mail: Thum.Thomas@mh-hannover.de
Get access Rights & Permissions [Opens in a new window]

Abstract

Organ transplantation has evolved rapidly and there is now widespread use of donated organs for the treatment of end-stage organ failure. Although the therapeutic options achieving long-term graft survival have improved, acute and chronic rejections are still a major problem. Studies to identify noninvasive biomarkers for rejection and underlying molecular events have increased significantly in the past decade, but a major breakthrough is still missing. The recent discovery of small regulatory RNA molecules (microRNAs) resulted in a new and improved understanding of the mechanisms of gene regulation and also led to the development of the first new microRNA (miRNA)-based therapies. miRNAs are endogenous, single-stranded RNAs consisting of about 19–25 noncoding nucleotides, which have an important role in regulating gene expression. Additionally, circulating miRNAs that might be useful as novel disease biomarkers were detected. Here, we summarise current knowledge about the role of miRNAs in immunology and transplantation medicine and their role as potential biomarkers. We also focus on the molecular mechanisms and therapeutic implications of the use of miRNA-based therapeutic strategies to improve long-term allograft survival.

Type
Review Article
Information
Expert Reviews in Molecular Medicine , Volume 13 , March 2011 , e37
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Meier-Kriesche, H.U., Schold, J.D. and Kaplan, B. (2004) Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 4, 1289-1295CrossRefGoogle ScholarPubMed
2Nankivell, B.J. et al. (2003) The natural history of chronic allograft nephropathy. The New England Journal of Medicine 349, 2326-2333CrossRefGoogle ScholarPubMed
3Colvin, R.B. (2007) Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. Journal of the American Society of Nephrology: JASN 18, 1046-1056CrossRefGoogle ScholarPubMed
4Tichelli, A. et al. (2009) Late complications after hematopoietic stem cell transplantation. Expert Review of Hematology 2, 583-601CrossRefGoogle ScholarPubMed
5Welniak, L.A., Blazar, B.R. and Murphy, W.J. (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annual Review of Immunology 25, 139-170CrossRefGoogle ScholarPubMed
6Zeiser, R. et al. (2004) Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Annals of Hematology 83, 551-565Google Scholar
7Bleakley, M. and Riddell, S.R. (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Reviews Cancer 4, 371-380CrossRefGoogle ScholarPubMed
8Copelan, E.A. (2006) Hematopoietic stem-cell transplantation. New England Journal of Medicine 354, 1813-1826Google Scholar
9Cahn, J.Y. et al. (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 106, 1495-1500CrossRefGoogle Scholar
10Kolb, H.J. (2008) Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 112, 4371-4383Google Scholar
11Melve, G.K. et al. (2011) The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target? Expert Review of Hematology 4, 563-576CrossRefGoogle ScholarPubMed
12Wysocki, C.A. et al. (2005) Leukocyte migration and graft-versus-host disease. Blood 105, 4191-4199CrossRefGoogle ScholarPubMed
13Muthukumar, T. et al. (2003) Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 75, 1565-1570Google Scholar
14Vasconcellos, L.M. et al. (1998) Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 66, 562-566Google Scholar
15Crispim, J.C. et al. (2009) Interleukin-17 and kidney allograft outcome. Transplantation Proceedings 41, 1562-1564CrossRefGoogle ScholarPubMed
16Suarez-Alvarez, B. et al. (2006) The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection. Transplantation 82, 354-361CrossRefGoogle Scholar
17Ramesh, G., Kwon, O. and Ahn, K. (2010) Netrin-1: a novel universal biomarker of human kidney injury. Transplantation Proceedings 42, 1519-1522CrossRefGoogle ScholarPubMed
18Hancock, W.W. et al. (2000) Requirement of the chemokine receptor CXCR3 for acute allograft rejection. Journal of Experimental Medicine 192, 1515-1520CrossRefGoogle ScholarPubMed
19Fahmy, N.M. et al. (2003) Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 75, 72-78CrossRefGoogle ScholarPubMed
20Thum, T., Catalucci, D. and Bauersachs, J. (2008) MicroRNAs: novel regulators in cardiac development and disease. Cardiovascular Research 79, 562-570Google Scholar
21Carthew, R.W. and Sontheimer, E.J. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655Google Scholar
22Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854Google Scholar
23Small, E.M. and Olson, E.N. (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342CrossRefGoogle ScholarPubMed
24Kim, V.N., Han, J. and Siomi, M.C. (2009) Biogenesis of small RNAs in animals. Nature Reviews. Molecular Cell Biology 10, 126-139Google Scholar
25Anglicheau, D. and Suthanthiran, M. (2008) Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 86, 192-199CrossRefGoogle ScholarPubMed
26Anglicheau, D. et al. (2009) MicroRNA expression profiles predictive of human renal allograft status. Proceedings of the National Academy of Sciences of the United States of America 106, 5330-5335CrossRefGoogle ScholarPubMed
27Monticelli, S. et al. (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biology 6, R71Google Scholar
28Merkerova, M., Belickova, M. and Bruchova, H. (2008) Differential expression of microRNAs in hematopoietic cell lineages. European Journal of Haematology 81, 304-310CrossRefGoogle ScholarPubMed
29Sui, W. et al. (2008) Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transplant Immunology 19, 81-85CrossRefGoogle ScholarPubMed
30Zhao, E. et al. (2004) Cloning and expression of human GTDC1 gene (glycosyltransferase-like domain containing 1) from human fetal library. DNA and Cell Biology 23, 183-187CrossRefGoogle ScholarPubMed
31Vogt, A. et al. (2005) Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1 +/−mice. Journal of Investigative Dermatology 124, 263-267CrossRefGoogle ScholarPubMed
32Valadi, H. et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9, 654-659CrossRefGoogle ScholarPubMed
33Godwin, J.G. et al. (2010) Identification of a microRNA signature of renal ischemia reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 107, 14339-14344Google Scholar
34Gupta, S.K., Bang, C. and Thum, T. (2010) Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circulation. Cardiovascular Genetics 3, 484-488Google Scholar
35Kumarswamy, R., Anker, S.D. and Thum, T. (2010) MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Circulation Research 106, e8; author reply e9CrossRefGoogle ScholarPubMed
36Hunter, M.P. et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694Google Scholar
37Li, J. et al. (2008) Improved RNA quality and TaqMan pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. BMC Biotechnology 8, 10Google Scholar
38Skog, J. et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology 10, 1470-1476Google Scholar
39Kosaka, N. et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. Journal of Biological Chemistry 285, 17442-17452Google Scholar
40Lawrie, C.H. (2010) microRNA expression in erythropoiesis and erythroid disorders. British Journal of Haematology 150, 144-151Google Scholar
41Lawrie, C.H. et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology 141, 672-675Google Scholar
42Corsten, M.F. et al. (2010) Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circulation. Cardiovascular Genetics 3, 499-506CrossRefGoogle Scholar
43Widera, C. et al. (2011) Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of Molecular and Cellular Cardiology 51, 872-875Google Scholar
44Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838CrossRefGoogle ScholarPubMed
45Volinia, S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103, 2257-2261CrossRefGoogle ScholarPubMed
46Laterza, O.F. et al. (2009) Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical Chemistry 55, 1977-1983CrossRefGoogle ScholarPubMed
47Lorenzen, J.M. et al. (2011) Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clinical Journal of the American Society of Nephrology 6, 1540-1546CrossRefGoogle ScholarPubMed
48Lorenzen, J.M. et al. (2011) Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. American Journal of Transplantation 11, 2221-2227CrossRefGoogle ScholarPubMed
49Mittelbrunn, M. et al. (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nature Communications 2, 282CrossRefGoogle Scholar
50Cullen, B.R. (2004) Derivation and function of small interfering RNAs and microRNAs. Virus Research 102, 3-9Google Scholar
51Akira, S. and Takeda, K. (2004) Functions of toll-like receptors: lessons from KO mice. Comptes Rendus Biologies 327, 581-589Google Scholar
52Fontana, L. et al. (2007) MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nature Cell Biology 9, 775-787Google Scholar
53Taganov, K.D. et al. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103, 12481-12486CrossRefGoogle ScholarPubMed
54Liang, T.J. and Qin, C.Y. (2009) The emerging role of microRNAs in immune cell development and differentiation. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 117, 635-643Google Scholar
55Lindsay, M.A. (2008) microRNAs and the immune response. Trends in Immunology 29, 343-351Google Scholar
56Zhang, J. et al. (2009) Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 113, 4586-4594Google Scholar
57Vigorito, E. et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847-859Google Scholar
58Lu, T.X. et al. (2009) MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. Journal of Immunology 182, 4994-5002Google Scholar
59Xiao, C. et al. (2008) Lympho- proliferative disease and autoimmunity in mice with in- creased miR-17–92 expression in lymphocytes. Nature Immunology 9, 405-414CrossRefGoogle Scholar
60Zhou, B. et al. (2007) MiR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America 104, 7080-7085Google Scholar
61Cullen, B.R. (2004) Transcription and processing of human microRNA precursors. Mol Cell 16, 861-865CrossRefGoogle ScholarPubMed
62Rai, D. et al. (2008) Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genetics and Cytogenetics 181, 8-15Google Scholar
63Chen, X.M. et al. (2007) A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. Journal of Biological Chemistry 282, 28929-28938Google Scholar
64Thai, T.H. et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316, 604-608Google Scholar
65Fulci, V. et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109, 4944-4951CrossRefGoogle ScholarPubMed
66Zhou, B. et al. (2007) miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America 104, 7080-7085Google Scholar
67Rodriguez, A. et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science (New York, N.Y.) 316, 608-611CrossRefGoogle ScholarPubMed
68Kluiver, J. et al. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. Journal of Pathology 207, 243-249Google Scholar
69Eis, P.S. et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America 102, 3627-3632Google Scholar
70Neilson, J.R. et al. (2007) Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes and Development 21, 578-589Google Scholar
71Wu, H. et al. (2007) miRNA profiling of naive, effector and memory CD8T cells. PLoS One 2, e1020CrossRefGoogle Scholar
72Xiao, C. et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159Google Scholar
73Li, Q.J. et al. (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161CrossRefGoogle ScholarPubMed
74Kersh, G.J. and Allen, P.M. (1996) Essential flexibility in the T-cell recognition of antigen. Nature 380, 495-498Google Scholar
75Thai, T.H. et al. (2007) Regulation of the germinal center response by microRNA-155. Science (New York, N.Y.) 316, 604-608Google Scholar
76Tam, W., Ben-Yehuda, D. and Hayward, W.S. (1997) bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Molecular and Cellular Biology 17, 1490-1502Google Scholar
77O'Connell, R.M. et al. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America 104, 1604-1609Google Scholar
78O'Connell, R.M. et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619CrossRefGoogle ScholarPubMed
79Haasch, D. et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cellular Immunology 217, 78-86CrossRefGoogle ScholarPubMed
80Harris, A., Krams, S.M. and Martinez, O.M. (2010) MicroRNAs as immune regulators: implications for transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10, 713-719Google Scholar
81Yang, X.O. et al. (2008) Regulation of inflammatory responses by IL-17F. Journal of Experimental Medicine 205, 1063-1075CrossRefGoogle ScholarPubMed
82Li, Z. et al. (2008) Gene expression profiling in autoimmune noninfectious uveitis disease. Journal of Immunology (Baltimore, MD: 1950) 181, 5147-5157CrossRefGoogle ScholarPubMed
83Chen, C.Z. et al. (2004) MicroRNAs modulate hemapoetic lineage differetation. Science 303, 83-86Google Scholar
84Li, Q.J. et al. (2007) MiR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161Google Scholar
85Chen, C.Z. et al. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, N.Y.) 303, 83-86CrossRefGoogle ScholarPubMed
86Fukao, T. et al. (2007) An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129, 617-631Google Scholar
87Johnnidis, J.B. et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129Google Scholar
88Lorenzen, J.M., Haller, H. and Thum, T. (2011) MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nature Reviews. Nephrology 7, 286-294Google Scholar
89Thum, T. et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts. Nature 456, 980-984CrossRefGoogle ScholarPubMed
90Thum, T. et al. (2011) Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. Journal of Clinical Investigation 121, 461, 2; author reply 462-463Google Scholar
91van Rooij, E. et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America 105, 13027-13032CrossRefGoogle ScholarPubMed
92Kalluri, R. and Neilson, E.G. (2003) Epithelial–mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation 112, 1776-1784Google Scholar
93Zeisberg, E.M. et al. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology: JASN 19, 2282-2287CrossRefGoogle ScholarPubMed
94Kumarswamy, R. et al. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partially mediated by microRNA-21. Arteriosclerosis, thrombosis and vascular biology (in press)Google Scholar
95Liu, G. et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. Journal of Experimental Medicine 207, 1589-1597Google Scholar
96Patrick, D.M. et al. (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. Journal of Clinical Investigation 120, 3912-3916CrossRefGoogle ScholarPubMed
97Zhang, Z. et al. (2009) MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Letters 583, 2009-2014CrossRefGoogle ScholarPubMed
98Zhong, X. et al. (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. Journal of the American Society of Nephrology 22, 1668-1681Google Scholar
99Bonauer, A. et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713Google Scholar